Ambu A/S (OTCMKTS:AMBBY) Sees Large Volume Increase – Should You Buy?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares saw strong trading volume on Wednesday . 700 shares traded hands during mid-day trading, an increase of 40% from the previous session’s volume of 500 shares.The stock last traded at $13.57 and had previously closed at $13.80.

Ambu A/S Stock Performance

The stock has a market capitalization of $3.19 billion, a PE ratio of 39.91 and a beta of 0.94. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.63 and a current ratio of 2.72. The firm’s 50 day moving average is $13.53 and its two-hundred day moving average is $14.67.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $0.07 EPS for the quarter. Ambu A/S had a net margin of 10.00% and a return on equity of 10.35%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.